Uhlmann India inaugurates new office and showcases blister packaging solutions
Uhlmann India marks the inauguration of its new office and hosts an in-house event with industry leaders, partners, and customers,…
Author
Zydus receives WHO acceptability for ZyVac TCV, eligible for UN agency purchases
ZyVac TCV, developed by Zydus Lifesciences, gains prequalification from WHO for global typhoid immunisation programmes
Parexel names Keri Mattox as Chief Business Officer
Keri Mattox joins Parexel with over 25 years of healthcare experience to support the company's growth and strategic transformation
Pfizer’s ABRYSVO RSV vaccine approved by FDA for broader adult use
The vaccine is now approved for adults aged 18 to 59 at higher risk of RSV-related respiratory illness, expanding its prior…
JB Pharma announces ESG commitments with launch of third sustainability report
JB Pharma outlines goals to reduce emissions, increase renewable energy use, and achieve water positivity by 2033 in its latest…
Opioid addiction market to reach $2.4 billion in 8MM by 2033: GlobalData
Opioid addiction market to reach $2.4 billion by 2033 amid rising cases and new non-opioid treatments, despite generic erosion
Zuranolone to face challenges in Japan’s MDD market despite demonstrating rapid onset of action:…
Shionogi's zuranolone faces hurdles in Japan's MDD market, balancing rapid efficacy against safety concerns and established…
Lupin appoints Claus Jepsen as President of Global Specialty
Claus Jepsen joins Lupin with over 30 years of experience in commercial strategy and portfolio management
Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease…
Tremfya's subcutaneous formulation may offer new flexibility for Crohn's disease treatment, positioning it as a key contender in…
Alembic secures USFDA approval for Diltiazem Hydrochloride extended-release capsules
Approval covers 120 mg, 180 mg, and 240 mg formulations for the treatment of hypertension and chronic stable angina